|
CCDC150 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.421600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.104400E-01 |
| Normal-vs-Stage2 |
7.176800E-01 |
| Normal-vs-Stage3 |
1.393450E-01 |
| Normal-vs-Stage4 |
1.812030E-01 |
| Stage1-vs-Stage2 |
8.678400E-01 |
| Stage1-vs-Stage3 |
8.514400E-02 |
| Stage1-vs-Stage4 |
9.756200E-02 |
| Stage2-vs-Stage3 |
1.014630E-01 |
| Stage2-vs-Stage4 |
1.463800E-01 |
| Stage3-vs-Stage4 |
6.531800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.302800E-01 |
| Normal-vs-AfricanAmerican |
2.644400E-01 |
| Normal-vs-Asian |
1.323820E-01 |
| Caucasian-vs-AfricanAmerican |
2.169400E-01 |
| Caucasian-vs-Asian |
6.304600E-03 |
| AfricanAmerican-vs-Asian |
2.971600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.920000E-01 |
| Normal-vs-Female |
8.640100E-02 |
| Male-vs-Female |
3.402100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.408800E-01 |
| Normal-vs-Extreme_Weight |
5.283000E-01 |
| Normal-vs-Obese |
7.168600E-01 |
| Normal-vs-Extreme_Obese |
2.676200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.130200E-01 |
| Normal_Weight-vs-Obese |
7.184000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.592800E-01 |
| Extreme_Weight-vs-Obese |
3.532400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.220000E-01 |
| Obese-vs-Extreme_Obese |
2.988400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.008600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.892000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.813400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.042200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.601000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.755000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.126000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.737000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.185000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.606000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.621600E-01 |
| Normal-VS-Type2 PRCC |
2.005600E-02 |
| Normal-VS-KIRP CIMP |
6.857600E-01 |
| Normal-VS-Unclassified PRCC |
4.334000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.996380E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.099800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.370000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.025900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.581200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.248400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.710960E-01 |
| Normal-vs-N1 |
2.400200E-02 |
| Normal-vs-N2 |
5.719600E-01 |
| N0-vs-N1 |
1.968030E-01 |
| N0-vs-N2 |
4.115800E-01 |
| N1-vs-N2 |
1.867840E-01 |
|
|
